Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Melitta Bilban"'
Autor:
Pierre Layrolle, Eric Goyenvalle, Damien Le Nihouannen, P. Pilet, Melitta Bilban, Guy Daculsi, Eric Aguado
Publikováno v:
Journal of Biomedical Materials Research Part A
Journal of Biomedical Materials Research Part A, Wiley, 2007, 81 (2), pp.399-408. ⟨10.1002/jbm.a.31058⟩
Journal of Biomedical Materials Research Part A, Wiley, 2007, 81 (2), pp.399-408. ⟨10.1002/jbm.a.31058⟩
Synthetic bone substitutes, such as calcium phosphate ceramics, give good results in clinical applications. In order to adapt to surgical sites, bioceramics come in the form of blocks or granules, and are either dense or porous. Combining these bioce
Autor:
Guy Daculsi, Melitta Bilban, Xavier Bourges, Reiner Spaethe, Jérôme Guicheux, Gilles Bluteau, P. Pilet
Publikováno v:
Biomaterials. 27:2934-2943
For many years, fibrin sealants were associated with bone substitutes to promote bone healing. However, the osteoblastic response to fibrin sealant components remains poorly documented. In this study, MC3T3-E1 osteoblastic cells were cultured on biph
Autor:
Nicole-Claudia Meisner, Peter Nussbaumer, Andreas Neubauer, Melitta Bilban, Stefan Jäger, Andreas Billich, Manfred Auer
Publikováno v:
ASSAY and Drug Development Technologies. 2:21-30
Steroid sulfatase is an enzyme that currently enjoys considerable interest as a potential drug target in the treatment of estrogen- and androgen-dependent diseases, in particular breast cancer. We have purified human steroid sulfatase to apparent hom
Publikováno v:
Journal of the American Chemical Society. 124:5431-5440
HUN-7293 (1), a naturally occurring cyclic heptadepsipeptide, is a potent inhibitor of cell adhesion molecule expression (VCAM-1, ICAM-1, E-selectin), the overexpression of which is characteristic of chronic inflammatory diseases. Representative of a
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 12:2093-2095
We investigated whether the benzophenone moiety can be used as core element of steroid sulfatase (STS) inhibitors. While 4- and 3-benzophenone-O-sulfamates inhibit STS with IC50 values between 5 and 7 μM irrespective of additional hydroxy and methox
Publikováno v:
ChemInform. 31
The screening for new inhibitors of steroid sulfatase requires an efficient test system. To overcome the shortcomings of the available discontinuous fluorimetric assay, several coumarin-type compounds were investigated as potential new substrates. 3,
Publikováno v:
ChemInform. 33
We investigated whether the benzophenone moiety can be used as core element of steroid sulfatase (STS) inhibitors. While 4- and 3-benzophenone-O-sulfamates inhibit STS with IC50 values between 5 and 7 μM irrespective of additional hydroxy and methox
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 10:967-969
The screening for new inhibitors of steroid sulfatase requires an efficient test system. To overcome the shortcomings of the available discontinuous fluorimetric assay, several coumarin-type compounds were investigated as potential new substrates. 3,
Publikováno v:
Clinical oral implants research. 20(10)
Objectives: The aim of this study was to assess the efficacy and safety of macroporous biphasic calcium phosphate (MBCP™)/fibrin grafts (TricOs®)/(Tisseel®) for sinus lift augmentation in sheep. Autologous bone grafts were used as a positive cont
Autor:
Claire Vinatier, Borhane H. Fellah, Guy Daculsi, M. Masson, Olivier Malard, Anne Moreau, Reiner Spaethe, Melitta Bilban, Olivier Gauthier, Jérôme Guicheux
Publikováno v:
Journal of biomedical materials research. Part A. 89(1)
Hybrid constructs associating a biodegradable matrix and autologous chondrocytes hold promise for the treatment of articular cartilage defects. In this context, our objective was to investigate the potential use of nasal chondrocytes associated with